Cargando…
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety
Hepatocellular carcinoma (HCC) is a severe complication of advanced liver disease with a worldwide incidence of more than 600,000 patients per year. Liver function, clinical performance status, and tumor size are considered in the Barcelona Clinic Liver Cancer (BCLC) system. While curative treatment...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804539/ https://www.ncbi.nlm.nih.gov/pubmed/24204170 http://dx.doi.org/10.2147/CMAR.S35029 |